Method for preparing pregabalin intermediate 3-isobutylglutaric acid monoamide

US10577309B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10577309-B2
Application numberUS-201716313262-A
CountryUS
Kind codeB2
Filing dateJun 21, 2017
Priority dateJun 30, 2016
Publication dateMar 3, 2020
Grant dateMar 3, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided is a method for preparing a pregabalin intermediate 3-isobutylglutaric acid monoamide. The method comprises: 1) adding 3-isobutylglutaric acid and urea into a first organic solvent; 2) keeping warm and refluxing when heated to 100-140° C.; 3) adding water when cooled to 70-90° C.; 4) adding an ion membrane alkaline when cooled to 40-60° C., adjusting the pH to 11.0-14.0, then keeping warm at 40-60° C.; 5) when finished keeping warm, removing an organic layer; 6) adding an acid into the water layer to adjust the pH to 1.0-3.0; 7) extracting the solution acquired in step 6) by using a second organic solvent of a total volume of V, vacuum distilling 0.5-0.6 V of the organic solvent from an organic layer acquired by extraction; and 8) cooling to 0-15° C. and crystallizing to acquire 3-isobutylglutaric acid monoamide.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for preparing a pregabalin intermediate 3-isobutylglutaric acid monoamide, comprising: 1) adding 3-isobutylglutaric acid and urea to a first organic solvent; 2) heating to a temperature of 100-140° C., and refluxing while maintaining the temperature; 3) cooling the mixture obtained in step 2) to 70-90° C., then adding water; 4) cooling the mixture obtained in step 3) to a temperature of 40-60° C., then adding an ion-exchange membrane caustic soda solution to adjust the pH value of the mixture to 11.0-14.0, while maintaining the temperature of 40-60° C.; 5) separating an organic layer after maintaining the temperature; 6) adding an acid into the aqueous layer to adjust the pH value of the aqueous layer to 1.0-3.0; 7) extracting the aqueous solution obtained in step 6) with a second organic solvent of a total volume of V, distilling the second organic layer obtained by extraction under reduced pressure to remove 0.5V-0.6 V of the second organic solvent; and 8) cooling the distilled second organic layer to 0-15° C. and crystallizing to obtain 3-isobutylglutaric acid monoamide. 2. The method according to claim 1 , wherein the ratio of the volume of the first organic solvent in step 1) in milliliters to the mass of 3-isobutylglutaric acid in grams is 2:1 to 6:1; and the mass ratio of urea to 3-isobutylglutaric acid is 0.2:1 to 0.6:1. 3. The method according to claim 1 , wherein the first organic solvent in step 1) is selected from the group consisting of toluene, xylene and octane. 4. The method according to claim 1 , wherein the duration of refluxing and maintaining the temperature in step 2) is 2.0 h to 5.0 h. 5. The method according to claim 1 , wherein the mass of water added in step 3) is 1.5 to 4.0 times as much as the mass of 3-isobutylglutaric acid. 6. The method according to claim 1 , wherein step 4) further comprises stirring and maintaining the temperature of the mixture at 40-60° C. for 0.5 h to 4.0 h. 7. The method according to claim 1 , wherein the second organic solvent in step 7) is selected from the group consisting of ethyl acetate, dichloromethane and toluene. 8. The method according to claim 1 , wherein the duration of crystallizing in step 8) is 1.0 h to 6.0 h. 9. The method according to claim 1 , further comprising centrifuging, filtering and drying the 3-isobutylglutaric acid monoamide after crystallizing in step 8).

Assignees

Inventors

Classifications

  • from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines · CPC title

  • C07C231/10Primary

    from compounds not provided for in groups C07C231/02 - C07C231/08 · CPC title

  • attached in positions 2 and 6, e.g. glutarimide · CPC title

  • having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10577309B2 cover?
Provided is a method for preparing a pregabalin intermediate 3-isobutylglutaric acid monoamide. The method comprises: 1) adding 3-isobutylglutaric acid and urea into a first organic solvent; 2) keeping warm and refluxing when heated to 100-140° C.; 3) adding water when cooled to 70-90° C.; 4) adding an ion membrane alkaline when cooled to 40-60° C., adjusting the pH to 11.0-14.0, then keeping w…
Who is the assignee on this patent?
Zhejiang Huahai Pharm Co Ltd, Zhejiang Huahai Zhicheng Pharmaceutical Co Ltd, Zhejiang Huahai Pharmaceuticals Co Ltd
What technology area does this patent fall under?
Primary CPC classification C07C231/10. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).